Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Clinical Genitourinary Cancer|October 10, 2009
Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castration-resistant prostate cancerSusan F Slovin, W Kevin Kelly, Andrew Wilton, et al.
The Journal of Urology|October 16, 2007
A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancerMichael J Morris, W Kevin Kelly, Susan Slovin, et al.
Nature Reviews. Urology|March 24, 2020
Cellular rewiring in lethal prostate cancer: the architect of drug resistanceMarc Carceles-Cordon, W Kevin Kelly, Leonard Gomella, et al.
World Journal of Urology|August 9, 2023
Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX dataSameh Gomaa, W Kevin Kelly, Edith Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapyRobert W Ross, Judith Manola, Kristen Hennessy, et al.
Cancer|December 12, 2003
A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813William K Oh, Susan Halabi, W Kevin Kelly, et al.
Clinical Prostate Cancer|October 4, 2005
Second-line chemotherapy for prostate cancer: patient characteristics and survivalKathleen W Beekman, Mark T Fleming, Howard I Scher, et al.
Cancer|December 6, 2005
A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma: second line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapyJonathan E Rosenberg, Matthew D Galsky, Nicholas C Rohs, et al.
Cancer|March 29, 2002
HER-2 profiling and targeting in prostate carcinomaMichael J Morris, Victor E Reuter, W Kevin Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castrationOren Smaletz, Howard I Scher, Eric J Small, et al.
Pageof 6